๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Esophageal Crohn's disease treated successfully with adalimumab

โœ Scribed by Lola Y. Kwan; Jeffrey L. Conklin; Konstantinos A. Papadakis


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
87 KB
Volume
13
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pityriasis lichenoides chronica induced
โœ B. Ben Said; J. Kanitakis; I. Graber; J.F. Nicolas; J.C. Saurin; F. Berard ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 1 views

Tumor necrosis factor alpha (TNF-a) inhibitors improve inflammatory diseases such as Crohn's disease (CD). However, these biologicals may induce infections, neoplasms, or autoimmune diseases. Cutaneous side effects have been reported, including dermatitis, psoriasis-like rash, and vasculitis. 1 We r

Adalimumab for cutaneous metastatic Croh
โœ Didia Bismara Cury; Alan C. Moss; Geraldo Elias; Alexandre Nakao ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 2 views
Adalimumab treatment for peristomal pyod
โœ Naim Alkhouri; Vera Hupertz; Lori Mahajan ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 3 views

PG) is an uncommon neutrophilic dermatosis first described by Brunsting et al in 1930. 1 It is a painful, chronic ulcerating inflammatory skin condition that appears to be immune-mediated. The characteristic lesion begins as small erythematous papules that rapidly spread concentrically, coalesce, an